Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Germline Variants in Bladder and Upper Tract Urothelial Cancers: Prevalence and Clinical Context in a Large Testing Registry.
Journal: European urology open science
Published: February 11, 2026
Real-World Outcomes of Patients With Baseline Neuropathy and/or Diabetes Mellitus Receiving Enfortumab Vedotin-Based Regimens for Advanced Urothelial Carcinoma in the UNITE Database.
Journal: Clinical genitourinary cancer
Published: December 02, 2025
The E3 ligase HECTD4 regulates COX-2-dependent tumor progression and metastasis.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: August 06, 2025
Pathogenic Germline Variant Prevalence and Genetic Testing Outcomes in Patients With Urothelial Carcinoma.
Journal: Clinical genitourinary cancer
Published: July 29, 2025
Efficacy of erdafitinib before or after enfortumab vedotin in FGFR3-altered advanced urothelial cancer: analysis of the UNITE collaborative study.
Journal: The oncologist
Published: June 09, 2025
MRI Can Replace Early Protocol Biopsy in Patients Undergoing Focal Cryoablation for Prostate Cancer.
MRI Can Replace Early Protocol Biopsy in Patients Undergoing Focal Cryoablation for Prostate Cancer.
Journal: Journal of endourology
Published: June 04, 2025
Outcomes with Enfortumab Vedotin in Patients with Histologic Subtypes of Advanced Urothelial Carcinoma: Analysis of the UNITE Study.
Journal: European urology
Published: May 07, 2025
Treatment-Related Adverse Events and Associated Outcomes in Patients With Advanced Urothelial Carcinoma Treated With Enfortumab Vedotin: Analysis of the UNITE Study.
Journal: Cancer medicine
Published: May 18, 2024
Novel Approaches with HIF-2α Targeted Therapies in Metastatic Renal Cell Carcinoma.
Journal: Cancers
Published: November 17, 2023
DrugMap: A quantitative pan-cancer analysis of cysteine ligandability.
Journal: Cell
Published: October 01, 2023
Unprocessed genomic uracil as a source of DNA replication stress in cancer cells.
Journal: Molecular cell
Published: May 16, 2023
Last Updated: 09/26/2026